179 related articles for article (PubMed ID: 32012397)
1. Use of omalizumab in the treatment of hypocomplementemic urticarial vasculitis.
Navarro-Navarro I; Jiménez-Gallo D; Villegas-Romero I; Linares-Barrios M
Dermatol Ther; 2020 Mar; 33(2):e13237. PubMed ID: 32012397
[No Abstract] [Full Text] [Related]
2. Urticarial Vasculitis Successfully Treated With Omalizumab.
Ermertcan AT; Aktaş A; Öztürk F; Temiz P
Cutis; 2021 May; 107(5):E19-E21. PubMed ID: 34288864
[No Abstract] [Full Text] [Related]
3. Cold urticarial vasculitis successfully treated with omalizumab.
Ayén-Rodríguez A; Llamas-Molina JM; Gálvez-Moreno M; Ruiz-Villaverde R
Int J Dermatol; 2023 Feb; 62(2):e77-e78. PubMed ID: 35167707
[No Abstract] [Full Text] [Related]
4. Hypocomplementemic urticarial vasculitis syndrome: a rare autoimmune entity.
Balasubramaniam D; Gottwald L; Dominiak N; Rettig N; Bedford-Lyon N; Ahmed M
Int J Dermatol; 2020 Dec; 59(12):e480-e481. PubMed ID: 32720358
[No Abstract] [Full Text] [Related]
5. A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.
Nucera E; Basta F; Buonomo A; Mezzacappa S; Margiotta DP; Antonelli Incalzi R; Schiavino D
J Investig Allergol Clin Immunol; 2017; 27(6):382-384. PubMed ID: 29199964
[No Abstract] [Full Text] [Related]
6. Successful Treatment of Hypocomplementemic Urticarial Vasculitis With Omalizumab: A Case Report.
Pérez Codesido S; Rosado Ingelmo A; Gómez de la Fuente E; García García E; Privitera Torres M; Tejedor Alonso MA
J Investig Allergol Clin Immunol; 2020 Jun; 30(3):211-212. PubMed ID: 32571766
[No Abstract] [Full Text] [Related]
7. Successful treatment of urticarial vasculitis with omalizumab in children: a case series.
Wang S; Fu L; Xiang X; Zhang B; Ma L; Xing H
Clin Exp Dermatol; 2023 Sep; 48(10):1145-1148. PubMed ID: 37227921
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate induced urticarial vasculitis.
Swarnkar B; Biswal S; Agarwal S; Gupta S
Dermatol Ther; 2021 Nov; 34(6):e15164. PubMed ID: 34676651
[No Abstract] [Full Text] [Related]
9. [Hypocomplementemic vasculitis treated with dapsone].
Hérault M; Mazet J; Beurey P; Cuny JF; Barbaud A; Schmutz JL; Bursztejn AC
Ann Dermatol Venereol; 2010; 137(8-9):541-5. PubMed ID: 20804899
[TBL] [Abstract][Full Text] [Related]
10. Hypocomplementemic Urticarial Vasculitis Syndrome.
Umemoto D; Nishioka H
J Clin Rheumatol; 2023 Apr; 29(3):e15-e16. PubMed ID: 36959201
[No Abstract] [Full Text] [Related]
11. Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.
Cherrez-Ojeda I; Vanegas E; Felix M; Mata VL; Cherrez A
BMC Dermatol; 2018 Oct; 18(1):8. PubMed ID: 30359231
[TBL] [Abstract][Full Text] [Related]
12. Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus.
Her MY; Song JY; Kim DY
J Korean Med Sci; 2009 Feb; 24(1):184-6. PubMed ID: 19270838
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab does not improve skin lesions in a patient with hypocomplementemic urticarial vasculitis syndrome.
Aurich S; Simon JC; Treudler R
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e395-e397. PubMed ID: 28273376
[No Abstract] [Full Text] [Related]
14. Successful treatment of normocomplementemic urticarial vasculitis with omalizumab: A report of three cases and literature review.
Rattananukrom T; Svetvilas P; Chanprapaph K
Asian Pac J Allergy Immunol; 2020 Dec; 38(4):286-289. PubMed ID: 30660172
[TBL] [Abstract][Full Text] [Related]
15. Urticarial vasculitis.
Chang S; Carr W
Allergy Asthma Proc; 2007; 28(1):97-100. PubMed ID: 17390766
[TBL] [Abstract][Full Text] [Related]
16. [McDuffie hypocomplementemic urticarial vasculitis. Two cases and review of the literature].
el Maghraoui A; Abouzahir A; Mahassine F; Tabache F; Bezza A; Ghafir D; Ohayon V; Archane MI
Rev Med Interne; 2001 Jan; 22(1):70-4. PubMed ID: 11218302
[TBL] [Abstract][Full Text] [Related]
17. Response of omalizumab in normocomplementemic urticarial vasculitis.
Chen YD; Krause K; Tu P; Zhao ZT; Maurer M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):2114-2117.e2. PubMed ID: 32145404
[No Abstract] [Full Text] [Related]
18. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
Highet AS
Br J Dermatol; 1980 Mar; 102(3):358-60. PubMed ID: 7370185
[No Abstract] [Full Text] [Related]
19. Urticaria and urticarial vasculitis.
Guha B; Youngberg G; Krishnaswamy G
Compr Ther; 2003; 29(2-3):146-56. PubMed ID: 14606344
[TBL] [Abstract][Full Text] [Related]
20. Refractory Normocomplementemic Urticarial Vasculitis Showing a Good Response to B-Cell Depletion Therapy.
Adwan M; Hanbali R; Farah RI
J Clin Rheumatol; 2021 Dec; 27(8S):S474-S475. PubMed ID: 31743269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
